POPULARITY
64 episodes with evidence based healthcare
2 episodes with evidence based healthcare
2 episodes with evidence based healthcare
2 episodes with evidence based healthcare
Over nearly 30 years, the Cochrane Acute Respiratory Infections Group has produced close to 200 reviews. One of their earliest, antibiotics for acute otitis media in children, was first published in 2000 and it was updated for the fourth time in November 2023. Here's two of the authors, Sharon Sanders and Paul Glasziou from the Institute for Evidence-Based Healthcare at Bond University in Australia to talk about the latest findings.
Over nearly 30 years, the Cochrane Acute Respiratory Infections Group has produced close to 200 reviews. One of their earliest, antibiotics for acute otitis media in children, was first published in 2000 and it was updated for the fourth time in November 2023. Here's two of the authors, Sharon Sanders and Paul Glasziou from the Institute for Evidence-Based Healthcare at Bond University in Australia to talk about the latest findings.
“It's no secret that our healthcare system is broken, and that people are having trouble accessing care,” says Colleen Kavanagh, who spent the first decade of her career working with hospitals to implement new technology and maximize profitability.“But to solve this problem quickly, we're asking the wrong questions, and we're asking them of the wrong people.” In this episode, host CMA's David Ciullo speaks with Colleen Kavanagh, CEO of SoulBeing, about Innovation in Healthcare Access: An Integrated Approach to Evidence Based Healthcare.Learn about leveraging existing mechanisms to help your teams find healthcare services more easily and affordably. Consider an expanded view of healthcare services that incorporates all aspects of physical, mental and emotional health to provide truly integrated support, and empower your team and their families to be their healthiest, happiest selves.
In this episode, Ajay Bhatt talks to Georgette Eaton, NIHR Doctoral Research Fellow, about her journey to applying and undertaking a DPhil in Evidence Based Healthcare at the University of Oxford. Looking at this through the lens of Georgette's journey, they discuss the application process to undertake a PhD, and some of the steps that are required to embark on this research pathway. A fascinating insight into what to consider if you want to pursue a career as a clinical academic, and some of the funding options available. For more information regarding this podcast connect with us: Email - acpenquirieslondon@hee.nhs.uk Facebook - https://www.facebook.com/nhsewte X - https://twitter.com/NHSE_WTE Instagram - https://www.instagram.com/nhse_wte/ A transcript of this episode is available here
“It's no secret that our healthcare system is broken and that people are having trouble accessing care,” says Colleen Kavanagh, who spent the first decade of her career working with hospitals to implement new technology and maximize profitability.“But to solve this problem quickly, we're asking the wrong questions, and we're asking them of the wrong people.” In this episode, host CMA's David Ciullo speaks with Colleen Kavanagh, CEO of SoulBeing, about Innovation in Healthcare Access: An Integrated Approach to Evidence-Based Healthcare.Learn about leveraging existing mechanisms to help your teams find healthcare services more easily and affordably. Consider an expanded view of healthcare services that incorporates all aspects of physical, mental, and emotional health to provide truly integrated support, and empower your team and their families to be their healthiest, happiest selves.
Dr Clare J Taylor, Academic GP, explores how we can use large, anonymised GP datasets to improve our understanding of heart failure management in primary care. Nearly all UK residents are registered with a general practice and data collected during routine consultations can be used by researchers to understand more about common diseases. Heart failure occurs when the heart has been damaged and is struggling to pump enough blood to meet the needs of the body. Patients can feel breathless, exhausted and have swollen legs but treatments to improve quality of life and outlook are available. In this lecture, Dr Taylor explores how we can use large, anonymised GP datasets to improve our understanding of heart failure management in primary care. With a focus on the patient throughout, she presents her recent work on heart failure diagnosis and survival to illustrate the power, and limitations, of using big GP data for research and to ultimately improve patient care. Part of the Evidence-Based Health Care programme. About the speaker: Dr Clare J Taylor is a Clinical Lecturer in the Nuffield Department of Primary Care Health Sciences. Her research explores heart failure in primary care using big data epidemiology, prospective studies, and qualitative work. The findings have been published in high-impact journals and informed national and European heart failure policy. Clare is also experienced in postgraduate teaching and doctoral supervision and was a member of the National Institute for Health and Care Excellence Chronic Heart Failure guideline committee. She also works as an NHS general practitioner.
Dr Gordon Guyatt provides a guest talk on how we should teach evidence-based medicine in the 21st century This free guest lecture is part of the Teaching Evidence-Based Practice module, part of the Oxford University Evidence-Based Health Care (EBHC) programme. About the speaker: Dr Gordon Guyatt is a Distinguished Professor in the Department of Clinical Epidemiology and Biostatistics, McMaster University and one of the founders of Evidence-Based Medicine. He has played a key role in over 30 major clinical studies (including both large-scale observational and randomized trials) and has extensive expertise in study methodology. As co-founder and co-chair of the GRADE working group, he has been intimately involved in the development and evolution of the GRADE approach. Questions? Please contact the Evidence-Based Health Care (EBHC) team by emailing: cpdhealth@conted.ox.ac.uk To stay informed of programme news, including lectures and research news, sign up to the EBHC mailing list: https://conted.us6.list-manage.com/subscribe?u=b349338a9a&id=9769482733
After nearly two years of COVID, how is the pharmaceutical industry faring? In this episode, we explore where drug companies were before the arrival of COVID and how they performed financially during the pandemic. And we hear about the ongoing tensions between profits and equitable access to vaccines.Featuring, Ray Moynihan, assistant professor at the Institute for Evidence-Based Healthcare at Bond University in Australia; Jérôme Caby, professor of corporate finance at Sorbonne Business School in Paris, France; Ana Santos Rutschman, assistant professor of law at Saint Louis University in the US; and Nicole Hassoun, professor of philosophy at Binghamton University, State University of New York in the US.And Ozayr Patel, digital editor at The Conversation in Johannesburg, South Africa, recommends some reading on the emergence of the Omicron variant of COVID-19. The Conversation Weekly is produced by Mend Mariwany and Gemma Ware, with sound design by Eloise Stevens. Our theme music is by Neeta Sarl. You can sign up to The Conversation's free daily email here. Full credits for this episode available here.Further reading:COVID vaccines offer the pharma industry a once-in-a-generation opportunity to reset its reputation. But it's after decades of big profits and scandals, by Ray Moynihan, Bond UniversityWhy Moderna won't share rights to the COVID-19 vaccine with the government that paid for its development, by Ana Santos Rutschman, Saint Louis UniversityThe US drug industry used to oppose patents – what changed? by Joseph M. Gabriel, Florida State UniversityThe hunt for coronavirus variants: how the new one was found and what we know so far, by a panel of experts in South AfricaOmicron is the new COVID kid on the block: five steps to avoid, ten to take immediately, by Shabir A. Madhi, University of the Witwatersrand See acast.com/privacy for privacy and opt-out information.
Genia Stephen helps kids with intellectual disabilities build inclusive lives at home, at school and in the community. She is the founder and host of the Good Things In Life For Kids With Disabilities Podcast and manages a community of parents of children with disabilities. Having a younger sister and son with disabilities and medical complexities led her to a lifetime of training in the disability field under premier thought leaders and mentors. With more than 20,000 downloads, her podcast now gives other parents access to her world-class disability parenting education, complete with courses and membership. She is a practicing midwife and medical advocate currently completing her MSc. in Evidence-Based Health Care at the University of Oxford. Featured in Travel Without Limits Magazine and Community Living Ontario, as well as multiple top-rated podcasts, Genia speaks about creating a positive vision for kids with disabilities, getting the good things in life through valued social roles and social capital, and medical safeguarding. Blog and Transcript:www.mychildwillthrive.com/evidence-based-pathways-to-the-good-things-in-life
Dr Anne-Marie Boylan and Dr Laura Griffith, explore the value of qualitative health research and discuss what it's really like to undertake qualitative research. Qualitative research is a naturalistic mode of inquiry. It is used to answer a variety of research questions that have relevance to health policy and practice. In this podcast, Dr Anne-Marie Boylan, Director of the Postgraduate Certificate in Qualitative Health Research Methods at the University of Oxford, and Dr Laura Griffith, a former academic who now works in public health, explore the value of qualitative health research and discuss what it's really like to undertake qualitative research. Speaker biography Dr Laura Griffith completed her PhD in Anthropology about Motherhood in the East End in 2006 completing research in London and Bangladesh. During this time she also worked as a consultant and was the Chair of the Management Board for Sure Start and actively involved in other public health projects. From there she started as a Research Fellow in Warwick as the PI for a project investigating the experiences of minority ethnic populations of acute psychiatric services. Next was leading a project at Aston University about multi-professional team working in Mental Health teams, and from there she moved to the Health Experiences Research Group, University of Oxford, where she completed modules on psychosis, giving up smoking and experiences of ECT for the renowned healthtalk.org. She went on to lecture at the University of Birmingham in the sociology of health, and led the Health and Well-being stream in the Institute for Research into Superdiversity. At Birmingham she left the academic side of health research and moved into health consultancy - normally working with partners from the third sector. She now works in public health. Date: 18 May 2021
Professor Kamal Mahtani and David Nunan interview Professor Paul Glasziou, Director of the Institute for Evidence-Based Healthcare at Bond University, about his experience of leadership and his work in capacity building through teaching and supervision. Professor Kamal Mahtani is Director of the Evidence-Based Health Care Leadership programme and David Nunan is Director of the PGCert in Teaching EBHC
Professor Kamal Mahtani and David Nunan interview Professor Paul Glasziou, Director of the Institute for Evidence-Based Healthcare at Bond University, about his experience of leadership and his work in capacity building through teaching and supervision. Professor Kamal Mahtani is Director of the Evidence-Based Health Care Leadership programme and David Nunan is Director of the PGCert in Teaching EBHC
Welcome to another episode of The Words Matter Podcast.In this episode of the CauseHealth Series, I'm speaking with Dr Roger Kerry about his Chapter 13 that he wrote for the CauseHealth book titled ‘Causal Dispositionalism and Evidence Based Healthcare' (read Roger's Chapter here).Roger is an Associate Professor in the Division of Physiotherapy and Rehabilitation Sciences, Faculty of Medicine and Health Sciences, University of Nottingham. He specialises on risks and adverse events of manual therapy, neck pain and headache as well as clinical reasoning (see his research here). He holds a PhD in Philosophy with the doctoral dissertation Causation and Evidence-Based Medicine (see here). On this episode we talk about: His background as a physiotherapist, educator and researcher and how causation has featured in these areas of his work. The development of CauseHealth of which he was a founding member of the network. Roger's Philosophy PhD which looked at causation in relation to EBM and how this related the CauseHealth project. The inferential gap or problem of induction The nature of clinical reasoning and clinical expertise. What is the ‘best available evidence' in relation to causal dispositionalism. Whether there is objective ‘Truth' in healthcare. What we ‘do' with RCTs, and what does dispositionalim do with/say about RCTs and how the theory may change or support our clinical and research methods. So this was an absolutely wonderful discussion with Roger, I'd been wanting to have him on the Podcast for ages- and it was well worth the wait. You'll hear him say at the end of our chat that it was like going three rounds with Mike Tyson…but the feeling was completely mutual given the ground that we both covered in the conversation. This is a real treat.If you liked the podcast, you'll love The Words Matter online course and mentoring to develop your clinical expertise - ideal for all MSK therapists.Follow Words Matter on:Instagram @Wordsmatter_education @TheWordsMatterPodcastTwitter @WordsClinicalFacebook Words Matter - Improving Clinical Communication★ Support this podcast on Patreon ★
In this episode Professor Tammy Hoffmann talks about research into the natural history of uncomplicated urinary tract infections that could have a big impact on conversations with women and treatment with antibiotics. She is a professor of Clinical Epidemiology and leads the Centre for Evidence-Informed Health Decisions in the Institute of Evidence-Based Healthcare, Bond University. Natural history of uncomplicated urinary tract infection without antibiotics: a systematic review Read the paper: https://doi.org/10.3399/bjgp20X712781 (https://doi.org/10.3399/bjgp20X712781) Uncomplicated urinary tract infections (UTIs) are a very common reason for general practice consultations and one of the most common reasons for the prescription of antibiotics. Informed decision making should consider the benefit/harm trade-off of antibiotic use and the natural course of the illness. The studies reviewed in this paper, which focused solely on women, demonstrated that UTI symptoms resolve spontaneously in approximately a third of women in the first 7–10 days. Current guideline recommendations from the National Institute for Health and Care Excellence are to delay prescribing by two days but the findings of this systematic review indicate that this may be too short a timeframe.
0:00:00 Introduction Richard Saunders 0:00:00 On the Search for those Elusive Ghosts An interview with Beth Darlington in London, UK. A paranormal investigator who has a very open-minded and fair approach to investigating the claims of the paranormal. https://www.accessparanormal.com 0:00:00 Logical Fallacies with Michelle Bijkersma This week Michelle looks at "The Anecdotal Evidence Fallacy". This is when you are swayed into taking up a position or belief based on isolated examples of data, poor data or personal experience, rather than reliable evidence. A Logical Fallacy is an error we can make in reasoning, but it usually crops up when we are discussing or arguing our point of view. 0:00:00 Typewriter Time Before the mighty space ship Solar Flare charted unknown regions of the galaxy, its original namesake was on a less well-known mission to the moon. With the voice talents of Jennifer Hathorn, Brian Dunning and Ben Radford. 0:00:00 More COVID-19 Foolishness From the dangerous to the ridiculous. More stories of foolishness during this time of COVID-19. https://www.news.com.au/lifestyle/health/health-problems/coronavirus-astrazeneca-vaccine-doctor-slams-covid19-antivaxxers/news-story/f16004f67ac400806ac9444f879f65bf https://www.news.com.au/lifestyle/health/health-problems/pete-evans-labelled-hypocrite-for-covid19-safety-measures-in-byron-healing-clinic/news-story/1811d8ff5a5a43f840a662fce4bc2832 https://www.skeptics.com.au/2020/07/19/call-to-action-on-anti-vaccination-bus-tour 0:00:00 Let's have a Random Rant with Dr Paulie Dr Paulie looks at a study about fighting COVID-19 misinformation on social media, and interviews Professor Tammy Hoffmann from the Institute for Evidence Based Healthcare at Bond University about critical thinking for school students. https://bond.edu.au/profile/tammy-hoffmann Also Skepticon 2020 https://www.skepticon.org.au Corona Conspiracy - Upload Images https://coronaconspiracy.cloud
Al interviews Genia Stephen. Genia Stephen is a speaker, host of the Good Things In Life podcast, and founder of Good Things in Life which helps parents support their kids with intellectual disabilities to build good inclusive lives at home, at school and in the community. Genia has a sister with an intellectual disability and a son with an intellectual disability. Her mother introduced her to important ideas and thought leaders early in her life. She is a Registered Midwife, International Board Certified Lactation Consultant and is currently completing her MSc in Evidence-Based Health Care at the University of Oxford. For more interviews subscribe to the Call Me Podcast on itunes: https://itunes.apple.com/us/podcast/call-me-al/id1441852995 Season 3 of the Call Me Podcast is brought to you by CONNECT Communities. CONNECT’s mission is to Make Lives Better. We achieve this by providing complex and specialized services for people living with brain injury and stroke in a nurturing and innovative community environment. Through our Life Redesign Model™, we empower people by applying our knowledge and experience to coach, challenge and motivate each person to reach their unique personal goals and build a fulfilling life for themselves. CONNECT is one of few organizations accredited through Accreditation Canada using the Acquired Brain Injury standards. For more information visit their website: https://connectcommunities.ca/
Até hoje não há tratamento medicamentoso que comprovadamente previna ou cure a covid-19 – apenas medidas e medicações de suporte. Mesmo assim, uma parcela da comunidade médica defende o que chama de tratamento precoce. Ele envolve um “kit” contendo drogas sem comprovação científica de eficácia, como vitaminas, antibiótico e vermífugo, além de uma droga usada contra a malária, a hidroxicloroquina, que já foi descartada para uso na covid-19 no mundo todo – com testes em milhares de pacientes mostrando que não traz melhora e pode causar efeitos colaterais sérios. Parte da população correu às farmácias atrás dos produtos, seja com receita médica, seja sem, se expondo aos riscos da automedicação. Além disso, o kit já foi distribuído por algumas Prefeituras, planos de saúde, e é defendido por membros do governo federal – o que é alvo de críticas entre cientistas. Nesta live, médicos e cientistas discutiram o que se sabe sobre as medicações incluídas no kit, os dilemas da prática médica durante a pandemia e as etapas da ciência que não podem ser puladas para trazer soluções para a saúde. Convidados Frederico Fernandes é doutor em Pneumologia e médico assistente no InCor do Hospital das Clínicas da Faculdade de Medicina da USP (FMUSP). Também atua no Instituto do Câncer do Estado de São Paulo (Icesp) e preside a Sociedade Paulista de Pneumologia e Tisiologia (SPPT). Izabella Pena é bióloga e pesquisadora no Whitehead Institute do Massachusetts Institute of Technology (MIT), em Boston, nos Estados Unidos. Atualmente, faz parte da luta pela educação científica por meio de divulgações em seu canal no YouTube e do trabalho na organização (Contracovid). Luis Claudio Correia é doutor e livre-docente em Cardiologia. É professor adjunto e diretor do Centro de Medicina Baseada em Evidências da Escola Bahiana de Medicina e Saúde Pública (Bahiana) e editor-chefe do Journal of Evidence Based Healthcare. Apresentação e produção: Luiza Caires Produção audiovisual: Kleison Paiva Edição de vídeo: Thales Figueiredo Edição de áudio: Guilherme Fiorentini
No teatro grego antigo, diante de um impasse narrativo, os autores valiam-se da figura de deuses que surgiam penduradas por máquinas e causavam uma solução mágica ao enredo, o que é chamado de Deus Ex Machina. O desejo dos médicos e da população de uma solução Deus Ex Machina à COVID-19 tem nos levado à irracionalidade no uso de drogas sem comprovação científica de eficácia. Confira esta reflexão do Dr. Lucas Zambon neste episódio da Rádio IBSP.Ofori-Asenso R, Agyeman AA. Irrational Use of Medicines-A Summary of Key Concepts. Pharmacy (Basel). 2016;4(4):35. Published 2016 Oct 28.(Link para o artigo)CORREIA, Luis Claudio et al. Physicians’ preference towards the non-evidence based hydroxychloroquine treatment for COVID-19: the pandemic effect. Journal of Evidence-Based Healthcare, [S.l.], v. 2, n. 1, july 2020. (Link para o artigo)"Rational Medicine" - A Review. Boston Med Surg J 1858; 59:189-194 (Link para o artigo)
On today’s show, Genia Stephen joins Amanda and Vickie in a conversation about what the coming school year might hold and the reasons that remote schooling might not be working for everyone. Genia Stephen helps kids with intellectual disabilities build inclusive lives at home, at school, and in the community. She is the founder and host of the Good Things In Life For Kids With Disabilities Podcast with more than 11,000 downloads and manages a community of parents of children with disabilities. Having a younger sister and son with disabilities and medical complexities led her to a lifetime of training in the disability field under premier thought leaders and mentors. Her podcast, courses, and membership now give other parents access to the world-class disability parenting education that she has enjoyed. She is a practicing midwife, medical advocate, and currently completing her MSc. in Evidence-Based Health Care at the University of Oxford. Featured in Travel Without Limits Magazine and Community Living Ontario publications, Genia speaks about creating a positive vision for kids with disabilities, getting the good things in life through valued social roles and social capital, and medical safeguarding. Show Highlights: Even under the best of conditions, sometimes school just isn’t going to be successful for many kids. Genia covers a number of reasons why remote education might not work. There is an overwhelming amount of pressure on parents to get it all done. Some students have never even logged in to Zoom for lessons. There needs to be a better level of understanding on all sides. Relationships and the social capital that a child has with others can make all the difference in learning. Parents must figure out for their own kids what their biggest priorities are. Genia’s work focuses on some of the ways that kids can make a difference in the lives of other people. Families are better positioned to be working on connectedness in relationships than they are to be working on curriculum, particularly within the context of pandemic restrictions. Kids can still serve academic goals, and Genia offers some ideas. There are many differently-abled kids who do not have connections outside their family circle, and this pandemic experience presents a unique opportunity to develop connections. Links/Resources: Thank you for listening! Don’t forget to SUBSCRIBE to the show to receive every new episode delivered straight to your podcast player every Tuesday. If you enjoyed this episode and believe in our message, then please help us get the word out about this podcast. Rate and Review this show in Apple Podcasts, Stitcher Radio, or Google Play. It helps other listeners find this show. Be sure to connect with us and reach out with any questions/concerns: Facebook Instagram Twitter IEP website This podcast is for informational and educational purposes only. It is not to be construed as legal advice specific to your circumstances. If you need help with any legal matters, be sure to consult with an attorney regarding your specific needs. Connect with Genia! Good Things in Life Stay Connected - Free Resources Facebook Group - Good Things in Life For Kids WithDisabilities Podcast
Recent results of the NELSON Lung Cancer Screening Trial reports reductions in lung-cancer survival but not overall survival - The desire to detect disease even earlier means Overdiagnosis is on the rise. However, the interpretation of screening trial results is problematic and often gives rise to significant uncertainties that go unanswered. Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience. This talk was held as part of the Evidence-Based Diagnosis and Screening module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Medical Statistics.
Recent results of the NELSON Lung Cancer Screening Trial reports reductions in lung-cancer survival but not overall survival - The desire to detect disease even earlier means Overdiagnosis is on the rise. However, the interpretation of screening trial results is problematic and often gives rise to significant uncertainties that go unanswered. Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience. This talk was held as part of the Evidence-Based Diagnosis and Screening module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Medical Statistics.
Join me as I chat with Genia from GoodThingsInLife.org. We're talking about our kids' social roles, ableism, inclusion, tokenism, inspiration porn, chronic grief and so much more.Please note: This is much longer than most of my podcast episodes. I decided to leave it as one for those who are able to listen in one sitting. Here is the Power of Roles event she mentions in the podcast.Genia Stephen is a speaker, host of the Good Things In Life podcast, and founder of Good Things in Life which helps parents support their kids with intellectual disabilities to build good inclusive lives at home, at school, and in the community. Genia has a sister with an intellectual disability and a son with an intellectual disability. Her mother introduced her to important ideas and thought leaders early in her life. She is a Registered Midwife, International Board Certified Lactation Consultant and is currently completing her MSc in Evidence-Based Health Care at the University of Oxford.Support the show (https://paypal.me/ADayInOurShoes)
Should doctors with commercial interests lead research on their products? Should we forget ‘conflicts’ and discuss ‘declarations of interest’ instead? Who should hold and maintain conflicts of interest registers for doctors? Should practicing doctors work with the pharma industry as well as serve on guideline committees? Should researchers with extensive financial interests be disqualified from studies of their own products? The Physician Payments Sunshine Act requires US manufacturers to collect, track and report all financial relationships with clinicians and teaching hospitals. Professor Heneghan will discuss the failings with the current system of reporting of conflicts in medicine, what’s been tried so far, and why it is time for a UK Sunshine Act. Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience. This talk was held as part of the Practice of Evidence-Based Health Care module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Systematic Reviews. Members of the public are welcome to attend.
Should doctors with commercial interests lead research on their products? Should we forget ‘conflicts' and discuss ‘declarations of interest' instead? Who should hold and maintain conflicts of interest registers for doctors? Should practicing doctors work with the pharma industry as well as serve on guideline committees? Should researchers with extensive financial interests be disqualified from studies of their own products? The Physician Payments Sunshine Act requires US manufacturers to collect, track and report all financial relationships with clinicians and teaching hospitals. Professor Heneghan will discuss the failings with the current system of reporting of conflicts in medicine, what's been tried so far, and why it is time for a UK Sunshine Act. Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience. This talk was held as part of the Practice of Evidence-Based Health Care module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Systematic Reviews. Members of the public are welcome to attend.
Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience. Professor Carl Heneghan will talk about his involvement in Tamiflu research that led to the discovery of 170,000 pages of clinical study reports, the subsequent development of Alltrials he was involved in and the current epidemic of publication and reporting bias that plagues much of the current research evidence. This talk was held as part of the Practice of Evidence-Based Health Care module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Systematic Reviews.
Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience. Professor Carl Heneghan will talk about his involvement in Tamiflu research that led to the discovery of 170,000 pages of clinical study reports, the subsequent development of Alltrials he was involved in and the current epidemic of publication and reporting bias that plagues much of the current research evidence. This talk was held as part of the Practice of Evidence-Based Health Care module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Systematic Reviews.
The global health burden of heart failure is high, both as the common end-point for many cardiovascular diseases (e.g. hypertension and heart attacks) and a common point on the trajectory of non-cardiovascular diseases (e.g. chronic respiratory disease). Despite advances in treatment, our ability to tailor strategies for prevention or management to individuals with heart failure is currently limited. Large-scale electronic health records and novel data analysis techniques have great potential to improve the status quo in both research and practice. In this talk, Amitava Banerjee examines the real progress and the limitations of recent big data research in heart failure, from epidemiology to machine learning. Amitava Banerjee is Associate Professor in Clinical Data Science at University College London, and Honorary Consultant Cardiologist at University College London Hospitals and Barts Health NHS Trusts. He is a pragmatic researcher, a passionate educator and a practising clinician, with interests spanning data science, cardiovascular disease, global health, training and evidence-based healthcare. After qualifying from Oxford Medical School, he trained as a junior doctor in Oxford, Newcastle, Hull and London. His interest in preventive cardiology and evidence-based medicine led to a Masters in Public Health at Harvard (2004/05), an internship at the World Health Organisation(2005) and DPhil in epidemiology from Oxford (2010). He was Clinical Lecturer in Cardiovascular Medicine at the University of Birmingham, before moving to UCL in 2015. He works across two busy tertiary care settings: University College London Hospitals and Barts Health NHS Trusts with both inpatient and outpatient commitments. Although he is subspecialised in heart failure, he has ongoing practice in acute general cardiology and a keen interest in the diagnosis and management of atrial fibrillation. His clinical work very much informs his research and vice versa, whether in the evaluation of medical technology or the ethics of large-scale use of patient data. This talk was held as part of the Big Data Epidemiology module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Medical Statistics.
The global health burden of heart failure is high, both as the common end-point for many cardiovascular diseases (e.g. hypertension and heart attacks) and a common point on the trajectory of non-cardiovascular diseases (e.g. chronic respiratory disease). Despite advances in treatment, our ability to tailor strategies for prevention or management to individuals with heart failure is currently limited. Large-scale electronic health records and novel data analysis techniques have great potential to improve the status quo in both research and practice. In this talk, Amitava Banerjee examines the real progress and the limitations of recent big data research in heart failure, from epidemiology to machine learning. Amitava Banerjee is Associate Professor in Clinical Data Science at University College London, and Honorary Consultant Cardiologist at University College London Hospitals and Barts Health NHS Trusts. He is a pragmatic researcher, a passionate educator and a practising clinician, with interests spanning data science, cardiovascular disease, global health, training and evidence-based healthcare. After qualifying from Oxford Medical School, he trained as a junior doctor in Oxford, Newcastle, Hull and London. His interest in preventive cardiology and evidence-based medicine led to a Masters in Public Health at Harvard (2004/05), an internship at the World Health Organisation(2005) and DPhil in epidemiology from Oxford (2010). He was Clinical Lecturer in Cardiovascular Medicine at the University of Birmingham, before moving to UCL in 2015. He works across two busy tertiary care settings: University College London Hospitals and Barts Health NHS Trusts with both inpatient and outpatient commitments. Although he is subspecialised in heart failure, he has ongoing practice in acute general cardiology and a keen interest in the diagnosis and management of atrial fibrillation. His clinical work very much informs his research and vice versa, whether in the evaluation of medical technology or the ethics of large-scale use of patient data. This talk was held as part of the Big Data Epidemiology module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Medical Statistics.
This evening lecture is given in conjunction with the Introduction to Study Design and Research Methods accredited short course, part of the Evidence-Based Healthcare programme at the University of Oxford's Department for Continuing Education. Carmen is a Public Health Nutrition scientist at the Department of Primary Care Health Sciences (University of Oxford). Her principal research interests lie in the prevention and management of non-communicable chronic disease through dietary improvements, in particular, obesity and cardiovascular disease. Diet is an important determinant of health, and food purchasing is a key antecedent to consumption hence improving the nutritional quality of food purchases presents a clear opportunity to intervene. She has been involved in a recent systematic review of interventions implemented in grocery stores which suggested that price manipulations, healthier swap suggestions, and perhaps manipulations to item availability change food purchasing and could play a role in public health strategies to improve health. However, the evidence base for interventions in grocery stores or at the individual level is still very limited. She is currently working on a range of studies aiming to examine the effectiveness of interventions based around healthier swaps on the quality of the food purchased and eaten as well as the short term effects on relevant health outcomes. She has recently conducted a complex behavioural intervention based in primary care to improve diet quality among patients with high cholesterol (PC-SHOP study). The intervention consisted of health professional (HP) advice alone, or in combination with personalised feedback based on the nutritional analysis of grocery store loyalty card data from one of the largest UK supermarkets. Overall her research aims to develop and test simpler and inexpensive ways to help people improve diet and prevent cardiovascular disease and obesity. This evening lecture is given in conjunction with the Introduction to Study Design and Research Methods accredited short course, part of the Evidence-Based Healthcare programme at the University of Oxford's Department for Continuing Education. Find out more.
This evening lecture is given in conjunction with the Introduction to Study Design and Research Methods accredited short course, part of the Evidence-Based Healthcare programme at the University of Oxford's Department for Continuing Education. Carmen is a Public Health Nutrition scientist at the Department of Primary Care Health Sciences (University of Oxford). Her principal research interests lie in the prevention and management of non-communicable chronic disease through dietary improvements, in particular, obesity and cardiovascular disease. Diet is an important determinant of health, and food purchasing is a key antecedent to consumption hence improving the nutritional quality of food purchases presents a clear opportunity to intervene. She has been involved in a recent systematic review of interventions implemented in grocery stores which suggested that price manipulations, healthier swap suggestions, and perhaps manipulations to item availability change food purchasing and could play a role in public health strategies to improve health. However, the evidence base for interventions in grocery stores or at the individual level is still very limited. She is currently working on a range of studies aiming to examine the effectiveness of interventions based around healthier swaps on the quality of the food purchased and eaten as well as the short term effects on relevant health outcomes. She has recently conducted a complex behavioural intervention based in primary care to improve diet quality among patients with high cholesterol (PC-SHOP study). The intervention consisted of health professional (HP) advice alone, or in combination with personalised feedback based on the nutritional analysis of grocery store loyalty card data from one of the largest UK supermarkets. Overall her research aims to develop and test simpler and inexpensive ways to help people improve diet and prevent cardiovascular disease and obesity. This evening lecture is given in conjunction with the Introduction to Study Design and Research Methods accredited short course, part of the Evidence-Based Healthcare programme at the University of Oxford's Department for Continuing Education. Find out more.
Fiona Godlee, Editor in Chief of The BMJ, gives a talk for the EBHC podcast series Fiona Godlee is the Editor in Chief of The BMJ. She qualified as a doctor in 1985, trained as a general physician in Cambridge and London, and is a Fellow of the Royal College of Physicians. She has written and lectured on a broad range of issues, including health and the environment, the ethics of academic publishing, evidence based medicine, access to clinical trial data, research integrity, open access publishing, patient partnership, conflict of interest, and overdiagnosis and overtreatment. After joining The BMJ as an assistant editor in 1990, she moved in 2000 to help establish the open access publisher BioMedCentral as its founding Editorial Director for Medicine. In 2003 she returned to BMJ to lead its Knowledge division and was appointed Editor in Chief of The BMJ in March 2005. Fiona is honorary professor at the Netherlands School for Primary Care Research (CaRe), honorary fellow of the Royal College of General Practitioners, a senior visiting fellow at the Institute of Public Health at the University of Cambridge, honorary fellow of the Faculty of Public Health and a by-fellow of King's College Cambridge. She is on the advisory or executive boards of the Health Improvement Studies (THIS) Institute (thisinstitute.cam.ac.uk), Alltrials (alltrials.net), the Peer Review Congress (peerreviewcongress.org), the International Forum for Quality and Safety and Healthcare (internationalforum.bmj.com), Evidence Live (evidencelive.org), Preventing Overdiagnosis (preventingoverdiagnosis.net), the UK Health Alliance on Climate Change (ukhealthalliance.org) and the Climate and Health Council. She was a Harkness Fellow (1994-5), President of the World Association of Medical Editors (WAME) (1998-2000), Chair of the Committee on Publication Ethics (COPE) (2003-5), and PPA Editor of the Year (2014). Fiona is co-editor of Peer Review in Health Sciences. She lives in Cambridge with her husband and two children.
Fiona Godlee, Editor in Chief of The BMJ, gives a talk for the EBHC podcast series Fiona Godlee is the Editor in Chief of The BMJ. She qualified as a doctor in 1985, trained as a general physician in Cambridge and London, and is a Fellow of the Royal College of Physicians. She has written and lectured on a broad range of issues, including health and the environment, the ethics of academic publishing, evidence based medicine, access to clinical trial data, research integrity, open access publishing, patient partnership, conflict of interest, and overdiagnosis and overtreatment. After joining The BMJ as an assistant editor in 1990, she moved in 2000 to help establish the open access publisher BioMedCentral as its founding Editorial Director for Medicine. In 2003 she returned to BMJ to lead its Knowledge division and was appointed Editor in Chief of The BMJ in March 2005. Fiona is honorary professor at the Netherlands School for Primary Care Research (CaRe), honorary fellow of the Royal College of General Practitioners, a senior visiting fellow at the Institute of Public Health at the University of Cambridge, honorary fellow of the Faculty of Public Health and a by-fellow of King’s College Cambridge. She is on the advisory or executive boards of the Health Improvement Studies (THIS) Institute (thisinstitute.cam.ac.uk), Alltrials (alltrials.net), the Peer Review Congress (peerreviewcongress.org), the International Forum for Quality and Safety and Healthcare (internationalforum.bmj.com), Evidence Live (evidencelive.org), Preventing Overdiagnosis (preventingoverdiagnosis.net), the UK Health Alliance on Climate Change (ukhealthalliance.org) and the Climate and Health Council. She was a Harkness Fellow (1994-5), President of the World Association of Medical Editors (WAME) (1998-2000), Chair of the Committee on Publication Ethics (COPE) (2003-5), and PPA Editor of the Year (2014). Fiona is co-editor of Peer Review in Health Sciences. She lives in Cambridge with her husband and two children.
Dr. Jason Busse is an Associate Professor in the Departments of Anesthesia and Clinical Epidemiology & Biostatistics, McMaster University. He is the co-Principle Investigator for the TRUST trial, one of the world’s largest orthopedic randomized controlled trials.TrainingDr. Busse completed an MSc in Medical and Molecular Genetics at the University of Toronto, a Doctorate in Chiropractic at CMCC, training in Cognitive Behavioral Therapy at McMaster University, and a PhD in Health Research Methodology at McMaster University.Dr. Busse has been active clinically in the management of disability secondary to chronic pain and other medically unexplained syndromes since 1999 and currently serves as the Clinical Director for Prisma Health Canada – a private company that manages chronic claimants (5+ years on disability) referred by private disability insurers. From 2001 to 2010 Dr. Busse was the Director of the Complex Claims Division for ATF Canada, a private company that provided assessment and treatment for patients in receipt of long-term disability benefits.ResearchDr. Busse has published over 150 peer-reviewed articles in scientific journals with a focus on chronic pain, orthopedic trauma, insurance medicine and methodological research. In 2011 Dr. Busse co-formed the evidence-based insurance medicine research group, an international collaboration with members from McMaster University, the University Medical Center Groningen, and the Academy of Swiss Insurance Medicine. He is a Director of the Cochrane Insurance Medicine Field Group (http://insuremed.cochrane.org/our-team). Current research projects include:FORESITE– a prospective cohort to establish factors associated with persistent post-surgical pain following heart surgeryUpdate and revision of the Canadian Guideline regarding opioids for chronic non-cancer painTeaching and Promotion of Evidence-Based Clinical PracticeSince 2011, Dr. Busse has been a tutor for the McMaster Evidence-Based Clinical Practice workshop, and an editor for the Newsletter of the International Society for Evidence-Based Health Care since 2009.Awards and Honours2015: McMaster University, HRM Mentoring/Supervision Award in the Full-Time/Joint Category2010: Outstanding Thesis Award, McMaster University, Faculty of Health Sciences Graduate Programs2009: New Investigator Award, Canadian Institute of Health Research2003: PhD Training Fellowship, Canadian Institute of Health Research
For many good reasons, semi-structured interviews, focus groups, thematic analysis, and realist tales have become key tools within the qualitative researcher's methodological toolkit. In this presentation, Dr Cassandra Phoenix invites the audience to consider the extent to which they may have (inadvertently) become the only tools within their toolkit. Drawing on examples from across the social sciences, she considers how else we might collect, analyse and represent qualitative data within health research, asking what it means and involves to truly advance qualitative research methods in this field. The short video played for the audience can be seen at: https://vimeo.com/43182928. Dr Cassandra Phoenix is a Reader in the Department for Health at the University of Bath. Her research examines ageing, health and wellbeing from a critical-socio-cultural perspective. She has authored numerous publications on topics including the social and cultural dimensions of: physical activity in mid and later life; the lived experiences of chronic conditions (e.g. late onset visual impairment, vestibular disorders); and engagement with nature. Cassandra's work is supported by a range of funders including ESRC, Wellcome Trust, Leverhulme Trust, WHO and the NIHR. This talk was held as part of the Advanced Qualitative Research Methods course which is part of the Evidence-Based Health Care Programme.
For many good reasons, semi-structured interviews, focus groups, thematic analysis, and realist tales have become key tools within the qualitative researcher's methodological toolkit. In this presentation, Dr Cassandra Phoenix invites the audience to consider the extent to which they may have (inadvertently) become the only tools within their toolkit. Drawing on examples from across the social sciences, she considers how else we might collect, analyse and represent qualitative data within health research, asking what it means and involves to truly advance qualitative research methods in this field. The short video played for the audience can be seen at: https://vimeo.com/43182928. Dr Cassandra Phoenix is a Reader in the Department for Health at the University of Bath. Her research examines ageing, health and wellbeing from a critical-socio-cultural perspective. She has authored numerous publications on topics including the social and cultural dimensions of: physical activity in mid and later life; the lived experiences of chronic conditions (e.g. late onset visual impairment, vestibular disorders); and engagement with nature. Cassandra's work is supported by a range of funders including ESRC, Wellcome Trust, Leverhulme Trust, WHO and the NIHR. This talk was held as part of the Advanced Qualitative Research Methods course which is part of the Evidence-Based Health Care Programme.
MEET THE GUEST: Genia started young with amazing mentors and a strong mother with a vision. Now, she’s a mother to two sons, a midwife to many, and an activist with a mission to band together with families to joyfully pursue the good things in life. Genia’s a registered midwife, International Board Certified Lactation Consultant, MSc in Evidence-Based Health Care (student), Speaker, Presenter, Podcast host, and founder of Good Things in Life which offers resources, courses and networking opportunities for a community of parents with a shared vision of the good things in life for their children with disabilities. In this episode, we cover: Genia’s introduction into special needs advocacy + social role valorization Setting expectations and raising the bar for our differently-abled children Creating a vision for ourselves and our children, and redefining what’s possible Starting her organization to reach families of children with disabilities Dealing with grief and moving past the sadness to learn to embrace the good things in life When asked for one piece of advice they’d give moms going through the grieving process of a new diagnosis, Genia says: “Everything wonderful in life happens on the other side of that cry. So you’ve got to get past the grief. Cause there are great, wonderful things on the other side of grief. Everything great is on the other side of special, so it’s worth it to go there.” Where To Connect with Genia Stephen Online: https://goodthingsinlife.org https://goodthingsinlife.org/podcast https://www.facebook.com/thegoodthingsinlife/ https://www.facebook.com/groups/351362831977895 (The Good Things In Life Facebook Group) Connect with Mia Francis-Poulin! Find out how you can work with Mia at www.racreative.co Catch up with Mia on Instagram. Join the Mama, Build Your Empire Group on Facebook.
Carl Heneghan asks the question, "What is driving the increase in diagnostic testing in healthcare?" and discusses why expectations, technology and the media are contributing to the problems of too much medicine and overdiagnosis. Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience. This talk was held as part of the Evidence-Based Diagnosis and Screening module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Medical Statistics.
Carl Heneghan asks the question, "What is driving the increase in diagnostic testing in healthcare?" and discusses why expectations, technology and the media are contributing to the problems of too much medicine and overdiagnosis. Carl Heneghan, Professor of Evidence-Based Medicine, employs evidence-based methods to research diagnostic reasoning, test accuracy and communicating diagnostic results to a wider audience. This talk was held as part of the Evidence-Based Diagnosis and Screening module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Medical Statistics.
Professor David Torgerson, Director of the York Trials Unit, gives a talk for the Evidence Based Healthcare podcast series. He has published widely with over 250 peer reviewed papers many of them on the design of randomised trials including a student text book 'Designing Randomised Trials in Health Education and the Social Sciences' (2008, Palgrave MacMillan). He has a particular interest in the design and conduct of cluster randomised trials. Randomisation, if conducted properly, will abolish selection bias. Poor randomisation practice for individually randomised trials allows the allocation schedule to be predicted and can lead to subversion of the randomisation, which introduces selection bias. In cluster randomised controlled trials there is a particular problem with some trials in that cluster randomisation occurs before individual recruitment. When this occurs the allocation can become known to the potential participant and the recruiting clinician and research. This, then, allows selective recruitment to occur which means that selection bias is introduced at the level of the individual participant. In this talk the problem is illustrated in case studies and I discuss approaches to dealing with this potential source of selection bias.
Professor David Torgerson, Director of the York Trials Unit, gives a talk for the Evidence Based Healthcare podcast series. He has published widely with over 250 peer reviewed papers many of them on the design of randomised trials including a student text book 'Designing Randomised Trials in Health Education and the Social Sciences' (2008, Palgrave MacMillan). He has a particular interest in the design and conduct of cluster randomised trials. Randomisation, if conducted properly, will abolish selection bias. Poor randomisation practice for individually randomised trials allows the allocation schedule to be predicted and can lead to subversion of the randomisation, which introduces selection bias. In cluster randomised controlled trials there is a particular problem with some trials in that cluster randomisation occurs before individual recruitment. When this occurs the allocation can become known to the potential participant and the recruiting clinician and research. This, then, allows selective recruitment to occur which means that selection bias is introduced at the level of the individual participant. In this talk the problem is illustrated in case studies and I discuss approaches to dealing with this potential source of selection bias.
Professor Mike Kelly, Primary Care Unit, Department of Public Health and Primary Care, Cambridge Institute of Public Health, University of Cambridge, gives a talk for the Evidence Based Healthcare seminar series. Professor Mike Kelly is Senior Visiting Fellow in the Department of Public Health and Primary Care at the Institute of Public Health and a member of St John's College at the University of Cambridge. Between 2005 and 2014, when he retired, he was the Director of the Centre for Public Health at the National Institute of Health and Care Excellence (NICE). From 2005 to 2007, he directed the methodology work stream for the World Health Organisation's (WHO) Commission on the Social Determinants of Health. His research interests include the prevention of non-communicable disease, living with chronic illness, health inequalities, health related behaviour change, end of life care, dental public health, the relationship between evidence and policy and the methods and philosophy of evidence based medicine. This talk will describe the approach to development of public health guidelines adopted by NICE (the National institute for Health and Care Excellence) between 2005 and 2014 when Mike Kelly was leading the public health team there. It will consider the influences that realist theories and methods had on the process which NICE engineered as it applied the conventional model of evidence based medicine to public health matters. Some of the academic opposition to this endeavour will be noted and the broader political environment described. Using the development of the guideline on the prevention of alcohol misuse as a case study, the paper will examine the political consequences of taking a realist approach to the evidence. The controversy, which ensued after NICE, published the guideline, which among other things recommended minimum unit pricing, will be analysed. Some of the lessons of working at the policy/practice/politics/academy interface will be discussed.
Professor Mike Kelly, Primary Care Unit, Department of Public Health and Primary Care, Cambridge Institute of Public Health, University of Cambridge, gives a talk for the Evidence Based Healthcare seminar series. Professor Mike Kelly is Senior Visiting Fellow in the Department of Public Health and Primary Care at the Institute of Public Health and a member of St John's College at the University of Cambridge. Between 2005 and 2014, when he retired, he was the Director of the Centre for Public Health at the National Institute of Health and Care Excellence (NICE). From 2005 to 2007, he directed the methodology work stream for the World Health Organisation's (WHO) Commission on the Social Determinants of Health. His research interests include the prevention of non-communicable disease, living with chronic illness, health inequalities, health related behaviour change, end of life care, dental public health, the relationship between evidence and policy and the methods and philosophy of evidence based medicine. This talk will describe the approach to development of public health guidelines adopted by NICE (the National institute for Health and Care Excellence) between 2005 and 2014 when Mike Kelly was leading the public health team there. It will consider the influences that realist theories and methods had on the process which NICE engineered as it applied the conventional model of evidence based medicine to public health matters. Some of the academic opposition to this endeavour will be noted and the broader political environment described. Using the development of the guideline on the prevention of alcohol misuse as a case study, the paper will examine the political consequences of taking a realist approach to the evidence. The controversy, which ensued after NICE, published the guideline, which among other things recommended minimum unit pricing, will be analysed. Some of the lessons of working at the policy/practice/politics/academy interface will be discussed.
Professor Alan Silman is an epidemiologist and a rheumatologist and is the co-author of 'Epidemiological Studies: A Practical Guide', which is the recommended textbook for the module 'Introduction to Study Design and Research Methods'. Alan Silman is currently Professor of Musculoskeletal Health at the University of Oxford. He was Director of the UK's Arthritis Research Epidemiology Unit in Manchester from 1988-2006, and then Medical Director of Arthritis Research UK, before moving to Oxford to take up his current position. He has published over 500 articles in the broad field of arthritis and musculoskeletal disease epidemiology. This talk was held as part of the Introduction to Study Design and Research Methods module, which is part of the MSc in Evidence-Based Health Care.
Professor Alan Silman is an epidemiologist and a rheumatologist and is the co-author of 'Epidemiological Studies: A Practical Guide', which is the recommended textbook for the module 'Introduction to Study Design and Research Methods'. Alan Silman is currently Professor of Musculoskeletal Health at the University of Oxford. He was Director of the UK's Arthritis Research Epidemiology Unit in Manchester from 1988-2006, and then Medical Director of Arthritis Research UK, before moving to Oxford to take up his current position. He has published over 500 articles in the broad field of arthritis and musculoskeletal disease epidemiology. This talk was held as part of the Introduction to Study Design and Research Methods module, which is part of the MSc in Evidence-Based Health Care.
Jamie Hartmann-Boyce is a Senior Researcher in Health Behaviours, based at the Nuffield Department of Primary Care Health Sciences, University of Oxford. Her work focusses on obesity and tobacco control and her particular interests lie in evidence synthes Though the vast majority of people trying to lose weight do so on their own, without support from healthcare professionals or formal weight loss programmes, most research into weight loss focuses on more intensive programmes. We therefore set out to find out more about what people do when trying to lose weight on their own. As part of this work, we conducted three qualitative systematic reviews to explore people's experiences with self-directed weight loss. The first review provides an overview of the cognitive and behavioural strategies used during self-directed weight loss attempts, and the second two reviews delve further into particular weight loss strategies that emerged as part of the overview, namely self-monitoring and reframing. In this talk, I'll cover key findings from each of the three reviews, and also use these reviews to illustrate how qualitative syntheses can be conducted and used to shed light on people's experiences. This talk was held as part of the Qualitative Research Methods module which is part of the MSc in Evidence-Based Health Care.
Jamie Hartmann-Boyce is a Senior Researcher in Health Behaviours, based at the Nuffield Department of Primary Care Health Sciences, University of Oxford. Her work focusses on obesity and tobacco control and her particular interests lie in evidence synthes Though the vast majority of people trying to lose weight do so on their own, without support from healthcare professionals or formal weight loss programmes, most research into weight loss focuses on more intensive programmes. We therefore set out to find out more about what people do when trying to lose weight on their own. As part of this work, we conducted three qualitative systematic reviews to explore people's experiences with self-directed weight loss. The first review provides an overview of the cognitive and behavioural strategies used during self-directed weight loss attempts, and the second two reviews delve further into particular weight loss strategies that emerged as part of the overview, namely self-monitoring and reframing. In this talk, I'll cover key findings from each of the three reviews, and also use these reviews to illustrate how qualitative syntheses can be conducted and used to shed light on people's experiences. This talk was held as part of the Qualitative Research Methods module which is part of the MSc in Evidence-Based Health Care.
Dr Jeffrey Aronson gives a talk for the Evidence Based Healthcare series.
Professor Mike Clarke gives a talk for the Evidence Based Healthcare series.
Professor Mike Clarke gives a talk for the Evidence Based Healthcare series.
Dr Jeffrey Aronson gives a talk for the Evidence Based Healthcare series.
Professor Carl Heneghan gives a talk for the Evidence Based Healthcare series. Patients are being let down by serious flaws in the creation, dissemination, and implementation of medical research. Too much of the resulting research evidence is withheld or disseminated only piecemeal. As the volume of clinical research activity has grown, the quality of evidence has often worsened, which has compromised medicine's ability to provide affordable, effective, high-value care for patients. Professor Carl Heneghan will discuss the CEBM initiatives that have grown out of EBM Live, a yearly conference designed to "develop, disseminate, and implement better evidence for better healthcare. He is Director of CEBM, and an NHS Urgent Care GP, and has been interested for over twenty years in how we can use evidence in real world practice. In preparation for this talk you are invited to read the following: https://doi.org/10.1136/bmj.j2973
Professor Carl Heneghan gives a talk for the Evidence Based Healthcare series. Patients are being let down by serious flaws in the creation, dissemination, and implementation of medical research. Too much of the resulting research evidence is withheld or disseminated only piecemeal. As the volume of clinical research activity has grown, the quality of evidence has often worsened, which has compromised medicine's ability to provide affordable, effective, high-value care for patients. Professor Carl Heneghan will discuss the CEBM initiatives that have grown out of EBM Live, a yearly conference designed to "develop, disseminate, and implement better evidence for better healthcare. He is Director of CEBM, and an NHS Urgent Care GP, and has been interested for over twenty years in how we can use evidence in real world practice. In preparation for this talk you are invited to read the following: https://doi.org/10.1136/bmj.j2973
Nearly half of medical procedures may not be based on sound science. That’s according to Eric Patashnik, director of Brown University’s public policy program. And he says it’s not necessarily your doctor’s fault. How did we get to this point? We put that question to Patashnik, who is co-author of the new book, “Unhealthy Politics: The Battle over Evidence-Based Medicine.”
In this talk Karolina presented various types of study design she has used in trials of treatments for chronic pain. Karolina also discussed why blinding is important and why a placebo control may be necessary, even in surgical trials. This talk was held as part of the Introduction to Study Design and Research Methods module, which is part of the MSc in Evidence-Based Health Care.
In this talk Karolina presented various types of study design she has used in trials of treatments for chronic pain. Karolina also discussed why blinding is important and why a placebo control may be necessary, even in surgical trials. This talk was held as part of the Introduction to Study Design and Research Methods module, which is part of the MSc in Evidence-Based Health Care.
Nearly half of medical procedures may not be based on sound science. That’s according to Eric Patashnik, director of Brown University’s public policy program. And he says it’s not necessarily your doctor’s fault. How did we get to this point? We put that question to Patashnik, who is co-author of the new book, “Unhealthy Politics: The Battle over Evidence-Based Medicine.”
Professor Carl Heneghan and Dr David Nunan from the Oxford Centre for Evidence-Based Medicine presented the launch of a new website that catalogues the important biases affecting health and medical research. The website is in response to a call-to-arms raised nearly 40 years ago by the late David Sackett, where he called for 'The continued development of an annotated catalog of bias. Each citation should include a useful definition, a referenced example illustrating the magnitude and direction of its effects, and a description of the appropriate preventive measures, if any. I volunteer for this task, would welcome collaboration, and would appreciate receiving nominations and examples of additional biases.' In honour of David's memory and legacy, the CEBM have taken up where he left off. We are now ready to share the catalogue with the rest of the world for welcome feedback, discussion and further evolution. Additional input from Professor Sir Iain Chalmers. This talk was held as part of the Practice of Evidence-Based Health Care course which is part of the Evidence-Based Health Care Programme.
Professor Carl Heneghan and Dr David Nunan from the Oxford Centre for Evidence-Based Medicine presented the launch of a new website that catalogues the important biases affecting health and medical research. The website is in response to a call-to-arms raised nearly 40 years ago by the late David Sackett, where he called for 'The continued development of an annotated catalog of bias. Each citation should include a useful definition, a referenced example illustrating the magnitude and direction of its effects, and a description of the appropriate preventive measures, if any. I volunteer for this task, would welcome collaboration, and would appreciate receiving nominations and examples of additional biases.' In honour of David's memory and legacy, the CEBM have taken up where he left off. We are now ready to share the catalogue with the rest of the world for welcome feedback, discussion and further evolution. Additional input from Professor Sir Iain Chalmers. This talk was held as part of the Practice of Evidence-Based Health Care course which is part of the Evidence-Based Health Care Programme.
Dr Katherine Pollard gives a talk for the Evidence Based Healthcare seminar series. This talk focuses on mixed methods research in health care education and practice, drawing on Kathy's experience of two large mixed methods projects to demonstrate salient issues: a longitudinal evaluation of an interprofessional undergraduate curriculum and a case study of quality measurement in community nursing. Kathy discusses research design and implementation, highlighting the challenges that arose, and the strategies employed to ensure successful project delivery. Dr Pollard has been an active researcher since 1998 and is currently employed as a Senior Research Fellow at the University of the Wet of England, Bristol. She has a clinical background in midwifery.
Dr Katherine Pollard gives a talk for the Evidence Based Healthcare seminar series. This talk focuses on mixed methods research in health care education and practice, drawing on Kathy's experience of two large mixed methods projects to demonstrate salient issues: a longitudinal evaluation of an interprofessional undergraduate curriculum and a case study of quality measurement in community nursing. Kathy discusses research design and implementation, highlighting the challenges that arose, and the strategies employed to ensure successful project delivery. Dr Pollard has been an active researcher since 1998 and is currently employed as a Senior Research Fellow at the University of the Wet of England, Bristol. She has a clinical background in midwifery.
Muir Gray is now working with both NHS England and Public Health England to bring about a transformation of care with the aim of increasing value for both populations and individuals. Here he gives a talk on improving healthcare systems. Here are some questions we cannot answer after nearly 70 years of a purportedly National Health Service. The lecture will address these questions and how they can be answered. 1. Is the service for people with seizures and epilepsy in Manchester of higher value than the service in Liverpool? 2. How many liver disease services are there in England and how many should there be? 3. Which service for people at the end of life in London provides the best value? 4. Is the service for people with asthma of higher than the service in Somerset? 5. How many services are there for people with MusculoSkeletal Disease in the North East, and which gives best value? We cannot answer them because we deliver care that is institutionally based not population based but to do so will need new knowledge and skills to answer questions such as: 1. What do you understand by the term complexity? 2. What is meant by the term system and how does it differ from a network? 3. What is meant by population based healthcare rather than bureaucracy based care? 4. What are the three meanings of the term value in 21st Century healthcare? Not ‘values' as in 'we value diversity' but the economic meanings 5. What is the relationship between value and efficiency? 6. What is meant by the optimal use of resources? 7. What is meant by the term quality and how does it relate to value? 8. What is a system and a standard? 9. How would you assess the culture of an organisation? 10. How would you decide if an organisation had a strong culture of stewardship? Muir Gray is now working with both NHS England and Public Health England to bring about a transformation of care with the aim of increasing value for both populations and individuals and published a series of How To Handbooks for example, How to Get Better Value Healthcare, How To Build Healthcare Systems and How To Create the Right Healthcare Culture. His hobby is ageing and how to cope with it and he has published a book for people aged seventy called Sod 70! and one for the younger decade called Sod 60! This with Dr Claire Parker, and his book for people aged 40-60, titled Midlife, appeared in January 2017. Other books in the series on Sod Ageing are Sod it, Eat Well, with Anita Bean and Sod Sitting, Get Moving with Diana Moran, the Green Goddess. For people of all ages Dr Gray's Walking Cure summarises the evidence on this wonderful means of feeling well, reducing the risk of disease and minimising disability should disease strike. This talk was held as part of the Practice of Evidence-Based Health Care course which is part of the Evidence-Based Health Care Programme.
Muir Gray is now working with both NHS England and Public Health England to bring about a transformation of care with the aim of increasing value for both populations and individuals. Here he gives a talk on improving healthcare systems. Here are some questions we cannot answer after nearly 70 years of a purportedly National Health Service. The lecture will address these questions and how they can be answered. 1. Is the service for people with seizures and epilepsy in Manchester of higher value than the service in Liverpool? 2. How many liver disease services are there in England and how many should there be? 3. Which service for people at the end of life in London provides the best value? 4. Is the service for people with asthma of higher than the service in Somerset? 5. How many services are there for people with MusculoSkeletal Disease in the North East, and which gives best value? We cannot answer them because we deliver care that is institutionally based not population based but to do so will need new knowledge and skills to answer questions such as: 1. What do you understand by the term complexity? 2. What is meant by the term system and how does it differ from a network? 3. What is meant by population based healthcare rather than bureaucracy based care? 4. What are the three meanings of the term value in 21st Century healthcare? Not ‘values’ as in 'we value diversity' but the economic meanings 5. What is the relationship between value and efficiency? 6. What is meant by the optimal use of resources? 7. What is meant by the term quality and how does it relate to value? 8. What is a system and a standard? 9. How would you assess the culture of an organisation? 10. How would you decide if an organisation had a strong culture of stewardship? Muir Gray is now working with both NHS England and Public Health England to bring about a transformation of care with the aim of increasing value for both populations and individuals and published a series of How To Handbooks for example, How to Get Better Value Healthcare, How To Build Healthcare Systems and How To Create the Right Healthcare Culture. His hobby is ageing and how to cope with it and he has published a book for people aged seventy called Sod 70! and one for the younger decade called Sod 60! This with Dr Claire Parker, and his book for people aged 40-60, titled Midlife, appeared in January 2017. Other books in the series on Sod Ageing are Sod it, Eat Well, with Anita Bean and Sod Sitting, Get Moving with Diana Moran, the Green Goddess. For people of all ages Dr Gray’s Walking Cure summarises the evidence on this wonderful means of feeling well, reducing the risk of disease and minimising disability should disease strike. This talk was held as part of the Practice of Evidence-Based Health Care course which is part of the Evidence-Based Health Care Programme.
A podcast about a song about vaping based on the latest evidence from research from Dr Jamie Hartmann-Boyce at the University of Oxford Vaping has exploded onto the scene as an new technology for smoking. Whilst there's a huge amount of debate about vaping in general there is one thing we know: for those already smoking, switching to vaping is much better for you. This interview explores the research behind how we know this, and features the song, 'The Great Vape Debate'. The song was written by Jonny Berliner in collaboration with Dr Jamie Hartmann-Boyce who works in the Cochrane Tobacco Addiction Group in the Nuffield Department of Primary Care Health Sciences at the University of Oxford. You can explore the research at http://www.cochranelibrary.com/ and on Twitter @CochraneTAG. views stated and expressed in this song are entirely personal, and do not represent any official views or opinions of Cochrane.
Dr John MacArtney gives a talk for the Evidence Based Healthcare seminar series. Qualitative researchers employ a range of different approaches to conducting qualitative analyses. In the process, they describe and interpret data, explaining the relationships between the patterns they find and interrogating their findings in various ways to provide thick descriptions of phenomena or explanatory theories. Drawing on his own qualitative analyses on experiences of cancer, Dr John MacArtney will explore some of the ways in which qualitative analysts approach these processes. This lecture will provide the opportunity to demystify an often intangible process and tackle some of the challenges facing qualitative health researchers today. Dr MacArtney is a Senior Researcher with the Nuffield Department of Primary Care Health Sciences at the University of Oxford and is a sociologist of health and illness with specific interests in the diagnosis of cancer, end of life and palliative care, and bereavement. He specialises in qualitative research. This talk was held as part of the Qualitative Research Methods module which is part of the MSc in Evidence-based Health Care.
Dr John MacArtney gives a talk for the Evidence Based Healthcare seminar series. Qualitative researchers employ a range of different approaches to conducting qualitative analyses. In the process, they describe and interpret data, explaining the relationships between the patterns they find and interrogating their findings in various ways to provide thick descriptions of phenomena or explanatory theories. Drawing on his own qualitative analyses on experiences of cancer, Dr John MacArtney will explore some of the ways in which qualitative analysts approach these processes. This lecture will provide the opportunity to demystify an often intangible process and tackle some of the challenges facing qualitative health researchers today. Dr MacArtney is a Senior Researcher with the Nuffield Department of Primary Care Health Sciences at the University of Oxford and is a sociologist of health and illness with specific interests in the diagnosis of cancer, end of life and palliative care, and bereavement. He specialises in qualitative research. This talk was held as part of the Qualitative Research Methods module which is part of the MSc in Evidence-based Health Care.
Professor Jeffrey Aronson, Consultant Physician and Clinical Pharmacologist, gives a talk for the Evidence Based Healthcare lecture series,
Professor Jeffrey Aronson, Consultant Physician and Clinical Pharmacologist, gives a talk for the Evidence Based Healthcare lecture series,
The overwhelming volume of evidence and its lack of relevance to patient care and decisions means health professionals require skills to sift evidence more efficiently: discarding what doesn't make a difference to focus on evidence that matters for health This talk will present a simple effective appraisal system based on two first steps to rapidly appraise and sift the evidence for its relevance and application to actual patient care, prior to assessing its validity. Professor Carl Heneghan is Director of CEBM, and an NHS Urgent Care GP, and has been interested for over twenty years in how we can use evidence in real world practice. This talk is being held as part of the Practice of Evidence-Based Health Care module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Systematic Reviews.
The overwhelming volume of evidence and its lack of relevance to patient care and decisions means health professionals require skills to sift evidence more efficiently: discarding what doesn't make a difference to focus on evidence that matters for health This talk will present a simple effective appraisal system based on two first steps to rapidly appraise and sift the evidence for its relevance and application to actual patient care, prior to assessing its validity. Professor Carl Heneghan is Director of CEBM, and an NHS Urgent Care GP, and has been interested for over twenty years in how we can use evidence in real world practice. This talk is being held as part of the Practice of Evidence-Based Health Care module which is part of the MSc in Evidence-Based Health Care and the MSc in EBHC Systematic Reviews.
Professor Trish Greenhalgh and Kamal R. Mahtani in conversation in the third episode of Trust The Evidence.
Professor Carl Heneghan, Director of the Centre for Evidence-Based Medicine, speaks to Professor Sir David Spiegelhalter, Winton Professor of the Public Understanding of Risk at the University of Cambridge, about the importance of medical statistics.
Richard Gleave, Public Health England and Professor Sue Dopson, Said Business School give a talk for the Green Templeton Lectures 2017: Delivering Health: Clinical, Management and Policy Challenges. The challenges presented when attempting to get research evidence into medical practice are notorious and, because of this, there exists a healthcare gap which warrants discussion. The relationship between the professions, management and government inevitably leads to one important question: 'who is accountable for quality improvement?' This lecture explored the term 'accountability' in relation to evidence based healthcare, and outlined the difficulties faced when attempting to implement research in both policy and medicine. For those of you weren't able to make it to this instalment of the Green Templeton Lectures, we have provided a full summary of the talk (PDF).
Dr Merlin Willcox gives a talk for the Evidence Based Healthcare series. Merlin’s research focuses on global health, particularly primary health care in low-income countries. In such countries, maternal and child mortality is significantly greater than in the UK – one in five children die before their fifth birthday. Primary health care has the potential to save most of these lives, if it is implemented according to best evidence. In this talk Merlin talks about the different studies and designs he has used in his work trying to address child mortality in Africa.
Dr Merlin Willcox gives a talk for the Evidence Based Healthcare series. Merlin's research focuses on global health, particularly primary health care in low-income countries. In such countries, maternal and child mortality is significantly greater than in the UK – one in five children die before their fifth birthday. Primary health care has the potential to save most of these lives, if it is implemented according to best evidence. In this talk Merlin talks about the different studies and designs he has used in his work trying to address child mortality in Africa.
Professor Carl Heneghan gives a talk for the MSc in Evidence-Based Health Care programme.
Professor Carl Heneghan gives a talk for the MSc in Evidence-Based Health Care programme.
In this episode of the Pulse podcast, we’re discussing what’s next in evidence-based healthcare with Dr. Brian Fengler, founder and CEO of EvidenceCare. We met with Dr. Fengler at the AAEM Scientific Assembly, organized by the American Academy of Emergency Medicine. We talked about the role data plays in evidence-based healthcare as well as Dr. Fengler's passion and mission in this space. He also gave us a glimpse into what's in store for the future of EvidenceCare. “Every single day, every single patient encounter, one-on-one behind a closed door, what decisions are being made? What discussions are being had? And that patient walking out of the room, are they walking out of the room on the right therapy or the wrong therapy? Are they walking out of the room with a better understanding than what they came in with? If you can achieve that, from the bottom up, then you're going to fix a lot of problems in healthcare.”
Prof Aksel Tjora, Professor of Sociology at the Norwegian University of Science and Technology, gives a talk for the MSc in Evidence-Based Health Care programme. Demonstrating how the potential of qualitative analysis is developed by maintaining a strong inductive strategy of concept development.
Prof Aksel Tjora, Professor of Sociology at the Norwegian University of Science and Technology, gives a talk for the MSc in Evidence-Based Health Care programme. Demonstrating how the potential of qualitative analysis is developed by maintaining a strong inductive strategy of concept development.
Professor Carl Heneghan gives a talk for the MSc in Evidence-Based Health Care programme
Professor Carl Heneghan gives a talk for the MSc in Evidence-Based Health Care programme
Barbara Loe Fisher is president of the National Vaccine Information Center (NVIC), a non-profit charity she co-founded with parents of DPT vaccine injured children in 1982. For the past three decades, she has led a national, grassroots movement and public information campaign to institute vaccine safety reforms and informed consent protections in the public health system. She has researched, analyzed and publicly articulated the major issues involving the science, policy, law, ethics and politics of vaccination to become one of the world’s leading non-medical, consumer advocacy experts on the subject She is co-author of the seminal book DPT: A Shot in the Dark (Harcourt Brace Jovanovich 1985); (get links to books below)author of The Consumer’s Guide to Childhood Vaccines (1997);Vaccines, Autism & Chronic Inflammation: The New Epidemic (2008) and Reforming Vaccine Policy & Law: A Guide (2014). She is a video commentator for the NVIC Newsletter and Mercola Newsletter and a blogger atwww.VaccineAwakening.blogspot.com. Her long public record of vaccine safety and informed consent advocacy was featured in the 2011 award winning film documentary THE GREATER GOOD. Her 1985 book, DPT: A Shot in the Dark, which she co-authored with Harris Coulter, Ph.D., was the first major, well documented critique of America’s mass vaccination system calling for safety reforms and the right to informed consent to vaccination. She worked with Congress to include vaccine safety provisions in the National Childhood Vaccine Injury Act of 1986 and with parents of vaccine injured children to bring the issue of vaccine safety to public attention, including leading demonstrations at the Centers for Disease Control in Atlanta and the White House in 1986. She conducted research and developed a comprehensive library on childhood infectious diseases, vaccines and federal vaccine research, regulation and policymaking that serves as the foundation for information disseminated by NVIC. She coordinated five scientific conferences, including the 1989 International Scientific Workshop on Pertussis and Pertussis Vaccines and four International Public Conferences on Vaccination in 1997, 2000, 2002 and 2009. During the past 25 years, she has served as a consumer representative on vaccine advisory and public engagement committees, including the National Vaccine Advisory Committee (1988-1991); the Institute of Medicine Vaccine Safety Forum (1995-1998) where she helped coordinate five public workshops on vaccine safety issues; the FDA Vaccines and Related Biological Products Advisory Committee (1999-2002); the Vaccine Policy Analysis Collaborative (2002-2005); the Vaccine Safety Writing Group (2009) and is a member of the Consumer’s United for Evidence-Based Healthcare, Cochrane Collaboration – U.S. She provides public comment at federal health agency meetings, has testified in Congress and state legislative hearings and is a featured speaker at health care conferences. Barbara has been quoted on the subject of vaccine safety and informed consent to vaccination in national news reports including the New York Times, Wall Street Journal, Washington Post, USA Today, Time, and Newsweek. Since 1993, she has debated more doctors on the subject of vaccination than any other American, including on NBC’s “The Today Show,” as well as on CNN, CBS, Fox, MSNBC, Al Jazeera America and National Public Radio. She has appeared in vaccine news reports on CBS “Sunday Morning News,” ABC “World News Tonight” ABC “Nightline,” PBS“Frontline” and CBS “The Doctors.” She has authored position statements and articles that have contributed to the national dialogue about vaccine safety and informed consent, including “The Moral Right to Conscientious, Philosophical and Personal Belief Exemption to Vaccination” (National Vaccine Advisory Committee 1997); “Shots in the Dark” (The Next City Magazine 1999); “Smallpox and Forced Vaccination: What Every American Needs to Know” (The Vaccine Reaction 2002); “In the Wake of Vaccines” (Mothering Magazine 2004); “Vaccines, Autism & Chronic Inflammation: The New Epidemic” (Autism File2009); “Whooping Cough Outbreaks and Vaccine Failures” (NVIC Newsletter 2010); “Doctors Denying Vaccine Risks: An American Tragedy” (NVIC Newsletter 2011); “Influenza Deaths: The Hype vs. the Evidence” (NVIC Newsletter 2012); “Measles Reports in America: What Does It mean?” (NVIC Newsletter 2013); and “Leave Parents Free to Choose Vaccines” (USA Today 2014). The daughter of a nurse and an Army officer, she graduated from the University of Maryland with a B.A. in English and was a writer and community relations professional at a teaching hospital before becoming a Mom in 1978. The mother of three grown children, her oldest son suffered a convulsion, collapse and brain inflammation within hours of his fourth DPT shot in 1980 when he was two and a half years old and was left with multiple learning disabilities and attention deficit disorder.
The Rapid diagnostic tests have the potential to reduce the overtreatment of malaria by 95%, but time and extensive logistical, behavioural, and technical interventions may be required to achieve this. Eleanor Ochodo from the Centre for Evidence-Based Health Care, at Stellenbosch University, joins us to discuss. Read the full article: http://www.bmj.com/content/352/bmj.i107
Carl Heneghan gives a talk held on January 11th 2016 Kellogg College. Recommended reading: Strunk Jr, W. and White, E.B. (1999) The Elements of Style, 4th Ed. Longman. ISBN: 978-0205309023. King, G. (2014) Improve Your Writing Skills, 1st Ed. Collins. Mathews, J., Bowen, J M. and Matthews, R W. (2000) Successful Scientific Writing, 2nd Ed. Cambridge University Press. ISBN: 978-0521789622. Seely, J. (2004) Oxford Everyday Grammar. Oxford University Press. ISBN:978-0198608745 Forsyth, M. (2014) The Elements of Eloquence: How to turn the perfect Englis phrase. Icon Books Ltd. ISBN: 978-1848317338 Gwynne, N M. (2013) Gwynne's Grammar. Ebury Press. ISBN: 978-0091951450 Murray, R. (2011) How to Write a Thesis, 3rd Ed. Open University Press. ISBN: 978-0335244287 Kane, T S. (1994) The New Oxford Guide to Writing. Oxford University Press. ISBN: 978-0195090598 King, S. (2012) On Writing. Hodder Paperbacks. ISBN:978-1444723250
Carl Heneghan gives a talk held on January 11th 2016 Kellogg College. Recommended reading: Strunk Jr, W. and White, E.B. (1999) The Elements of Style, 4th Ed. Longman. ISBN: 978-0205309023. King, G. (2014) Improve Your Writing Skills, 1st Ed. Collins. Mathews, J., Bowen, J M. and Matthews, R W. (2000) Successful Scientific Writing, 2nd Ed. Cambridge University Press. ISBN: 978-0521789622. Seely, J. (2004) Oxford Everyday Grammar. Oxford University Press. ISBN:978-0198608745 Forsyth, M. (2014) The Elements of Eloquence: How to turn the perfect Englis phrase. Icon Books Ltd. ISBN: 978-1848317338 Gwynne, N M. (2013) Gwynne's Grammar. Ebury Press. ISBN: 978-0091951450 Murray, R. (2011) How to Write a Thesis, 3rd Ed. Open University Press. ISBN: 978-0335244287 Kane, T S. (1994) The New Oxford Guide to Writing. Oxford University Press. ISBN: 978-0195090598 King, S. (2012) On Writing. Hodder Paperbacks. ISBN:978-1444723250
In this episode we welcome special guest nvic.org founder Barbara Loe Fisher to the show. Barbara Loe Fisher is president of the National Vaccine Information Center (NVIC), a non-profit charity she co-founded with parents of DPT vaccine injured children in 1982. For the past three decades, she has led a national, grassroots movement and public information campaign to institute vaccine safety reforms and informed consent protections in the public health system. She has researched, analyzed and publicly articulated the major issues involving the science, policy, law, ethics and politics of vaccination to become one of the world’s leading non-medical, consumer advocacy experts on the subject She is co-author of the seminal book DPT: A Shot in the Dark (Harcourt Brace Jovanovich 1985); author of The Consumer's Guide to Childhood Vaccines (1997); Vaccines, Autism & Chronic Inflammation: The New Epidemic (2008) and Reforming Vaccine Policy & Law: A Guide (2014). She is a video commentator for the NVIC Newsletter and Mercola Newsletter and a blogger at www.VaccineAwakening.blogspot.com. Her long public record of vaccine safety and informed consent advocacy was featured in the 2011 award winning film documentary THE GREATER GOOD. Her 1985 book, DPT: A Shot in the Dark, which she co-authored with Harris Coulter, Ph.D., was the first major, well documented critique of America's mass vaccination system calling for safety reforms and the right to informed consent to vaccination. She worked with Congress to include vaccine safety provisions in the National Childhood Vaccine Injury Act of 1986 and with parents of vaccine injured children to bring the issue of vaccine safety to public attention, including leading demonstrations at the Centers for Disease Control in Atlanta and the White House in 1986. She conducted research and developed a comprehensive library on childhood infectious diseases, vaccines and federal vaccine research, regulation and policymaking that serves as the foundation for information disseminated by NVIC. She coordinated five scientific conferences, including the 1989 International Scientific Workshop on Pertussis and Pertussis Vaccines and four International Public Conferences on Vaccination in 1997, 2000, 2002 and 2009. During the past 25 years, she has served as a consumer representative on vaccine advisory and public engagement committees, including the National Vaccine Advisory Committee (1988-1991); the Institute of Medicine Vaccine Safety Forum (1995-1998) where she helped coordinate five public workshops on vaccine safety issues; the FDA Vaccines and Related Biological Products Advisory Committee (1999-2002); the Vaccine Policy Analysis Collaborative (2002-2005); the Vaccine Safety Writing Group (2009) and is a member of the Consumer’s United for Evidence-Based Healthcare, Cochrane Collaboration – U.S. She provides public comment at federal health agency meetings, has testified in Congress and state legislative hearings and is a featured speaker at health care conferences. Barbara has been quoted on the subject of vaccine safety and informed consent to vaccination in national news reports including the New York Times, Wall Street Journal, Washington Post, USA Today, Time, and Newsweek. Since 1993, she has debated more doctors on the subject of vaccination than any other American, including on NBC’s “The Today Show,” as well as on CNN, CBS, Fox, MSNBC, Al Jazeera America and National Public Radio. She has appeared in vaccine news reports on CBS “Sunday Morning News,” ABC “World News Tonight” ABC “Nightline,” PBS “Frontline” and CBS “The Doctors.” She has authored position statements and articles that have contributed to the national dialogue about vaccine safety and informed consent, including “The Moral Right to Conscientious, Philosophical and Personal Belief Exemption to Vaccination” (National Vaccine Advisory Committee 1997); “Shots in the Dark” (The Next City Magazine 1999); “Smallpox and Forced Vaccination: What Every American Needs to Know” (The Vaccine Reaction 2002); “In the Wake of Vaccines” (Mothering Magazine 2004); “Vaccines, Autism & Chronic Inflammation: The New Epidemic” (Autism File 2009); “Whooping Cough Outbreaks and Vaccine Failures” (NVIC Newsletter 2010); “Doctors Denying Vaccine Risks: An American Tragedy” (NVIC Newsletter 2011); “Influenza Deaths: The Hype vs. the Evidence” (NVIC Newsletter 2012); “Measles Reports in America: What Does It mean?” (NVIC Newsletter 2013); and “Leave Parents Free to Choose Vaccines” (USA Today 2014). The daughter of a nurse and an Army officer, she graduated from the University of Maryland with a B.A. in English and was a writer and community relations professional at a teaching hospital before becoming a Mom in 1978. The mother of three grown children, her oldest son suffered a convulsion, collapse and brain inflammation within hours of his fourth DPT shot in 1980 when he was two and a half years old and was left with multiple learning disabilities and attention deficit disorder.
Dr Helen Ashdown is a GP and Clinical Researcher in the Nuffield Department of Primary Care Health Sciences, University of Oxford. During her clinical academic training, she designed and led a study to investigate whether pain on going over speed bumps when travelling to hospital is a good diagnostic test for appendicitis. This was published in the 2012 Christmas edition of the British Medical Journal. She will describe her own bumpy journey through the process of answering a clinical question - navigating the tortuous course from research question, ethics, study design and recruitment through to Christmas radio shows.
Dr Helen Ashdown is a GP and Clinical Researcher in the Nuffield Department of Primary Care Health Sciences, University of Oxford. During her clinical academic training, she designed and led a study to investigate whether pain on going over speed bumps when travelling to hospital is a good diagnostic test for appendicitis. This was published in the 2012 Christmas edition of the British Medical Journal. She will describe her own bumpy journey through the process of answering a clinical question - navigating the tortuous course from research question, ethics, study design and recruitment through to Christmas radio shows.
Annette Pluddermann, Senior researcher DPCHS, gives an introduction to the Practice of Evidence-Based Health Care
Dr Carl Heneghan, the Director of the Centre of Evidence-Based Medicine, gives a brief welcome to the Programme in Evidence-Based Health Care.
Sharon Mickan, a Knowledge Translation Fellow in the Centre for Evidence Based Medicine, gives an introduction to the Masters in Evidence-Based Health Care.
8th October 2012 - Speakers: Dr Dave Spratt, Reader in Microbial Ecology, UCL Eastman Dental Institute “Microbial ecology”, Professor Jonathan Knowles, Professor of Biomaterials Science and Head of the Division of Biomaterials and Tissue Engineering, UCL Eastman Dental Institute, "Biomaterials for tissue regeneration”, Professor Nikolaos Donos, Director of Research and Chair of Department of Clinical Research, UCL Eastman Dental Institute, "Association between periodontaloral diseases and chronic diseases", Professor Richard Watt, Chair of Dental Public Health, Institute of Epidemiology & Health, “Impact of social inequalities to oral health” Followed by panel discussion, Panel: Dr Sean Nair (Reader in Cellular Microbiology, UCL Eastman Dental Institute), Professor Brian Henderson (Biossard Chair of Oral Biochemistry, UCL Eastman Dental Institute) Professor Stephen Porter (Institute Director, UCL Eastman Dental Institute), Professor Ian Needleman (Professor of Restorative Dentistry and Evidence-Based Healthcare,UCL Eastman Dental Institute), and speakers, Chair: Raymond MacAllister, Professor of Clinical Pharmacology, Director, UCL Division of Medicine
8th October 2012 - Speakers: Dr Dave Spratt, Reader in Microbial Ecology, UCL Eastman Dental Institute “Microbial ecology”, Professor Jonathan Knowles, Professor of Biomaterials Science and Head of the Division of Biomaterials and Tissue Engineering, UCL Eastman Dental Institute, "Biomaterials for tissue regeneration”, Professor Nikolaos Donos, Director of Research and Chair of Department of Clinical Research, UCL Eastman Dental Institute, "Association between periodontaloral diseases and chronic diseases", Professor Richard Watt, Chair of Dental Public Health, Institute of Epidemiology & Health, “Impact of social inequalities to oral health” Followed by panel discussion, Panel: Dr Sean Nair (Reader in Cellular Microbiology, UCL Eastman Dental Institute), Professor Brian Henderson (Biossard Chair of Oral Biochemistry, UCL Eastman Dental Institute) Professor Stephen Porter (Institute Director, UCL Eastman Dental Institute), Professor Ian Needleman (Professor of Restorative Dentistry and Evidence-Based Healthcare,UCL Eastman Dental Institute), and speakers, Chair: Raymond MacAllister, Professor of Clinical Pharmacology, Director, UCL Division of Medicine
© 2020-2025 Ivy Podcast Discovery LLC
